Brussels, 27/05/2005 (Agence Europe) - The European Commission has conditionally cleared under the EU Merger Regulation the proposed acquisition of Hexal, a German producer of generic medicines, and 67.7% of its US sister company Eon Labs, by Swiss pharmaceuticals company Novartis, in a deal which creates the largest European producer of generics. The Commission's clearance is subject to a number of conditions intended to safeguard competition in areas where the transaction raised...